31 "Lung Disease" clinical studies found.

• Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

  This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or ...

  Shadia Jalal, Md

• Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR ...

  This randomized phase III trial studies how well erlotinib hydrochloride compared to placebo works in treating patients with stage IB-IIIA ...

  Shadia Jalal, Md

• A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Placebo for Patients With ...

  This randomized phase III trial studies how well crizotinib works and compares it to placebo in treating patients with stage ...

  Shadia Jalal, Md

• Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy ...

  This randomized phase III trial studies how well nivolumab after surgery and chemotherapy work in treating patients with stage IB-IIIA ...

  Shadia Jalal, Md

• A Phase II Trial of Chemotherapy plus Pembrolizumab in patients with advanced NSCLC previously treated with PD-1 or PD-L1 Inhibitor

  This is a single-arm phase II study of continuation immunotherapy with pembrolizumab following initial benefit with a PD-1 or PD-L1 ...

  Greg Durm, Md

• Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab alone following Concurrent Chemoradiotherapy for Unresectable Stage IIIA ...

  The purpose of this study is to test the good and bad effects of the study drugs called nivolumab and ...

  Greg Durm, Md

• Phase I/II Trial Evaluating Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the Lung

  The purpose of this study is to test whether 5 fraction stereotactic ablative body radiation (SABR) is safe and improves ...

  Tim Lautenschlaeger, Md

• A Phase 1a/1b Study of an Anti-IDO-1 Agent (LY3381916) Administered Alone or in Combination with Anti-PD-L1 Checkpoint Antibody (LY3300054 ...

  The purpose of this study is to evaluate the safety of the study drug LY3381916 administered alone or in combination ...

  Shadia Jalal, Md

• Protocol for the collection and transfer of cystic fibrosis lungs for research purposes

  The goal of this project is to secure lung, tissue and blood samples of no clinical or diagnostic value from ...

  David Roe, Md

• The CHEC-SC Cohort Study: CHaractErizing CFTR Modulated Changes in Sweat Chloride and their Association with Clinical Outcomes (the CHEC-SC study)

  This study will collect contemporary sweat chloride values from cystic fibrosis patients prescribed and currently receiving commercially approved CFTR modulator ...

  Clement Ren, Md